Estonia vs Middle income: Cause of death, by non-communicable diseases, male
Estonia
80.2%
in 2021
Middle income
59.1%
in 2021
Estonia rank
20th
Middle income rank
21st
Cause of death, by non-communicable diseases, male over time
- Estonia
- Middle income
How they compare
Estonia currently reports 80.2% against 59.1% in Middle income, a difference of 21.1%.
That makes Estonia's figure about 1.4 times Middle income's.
Across all 6 years both countries report, Estonia has been ahead every year.
Estonia ranks 20th and Middle income ranks 21st of 185 countries.
Estonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | Middle income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.4% | 54.4% | 27.0% | Estonia |
| 2010s | 89.3% | 68.1% | 21.2% | Estonia |
| 2020s | 84.1% | 63.0% | 21.1% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Estonia or Middle income?
- Estonia, at 80.2% against 59.1% in Middle income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Estonia and Middle income?
- 21.1%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Middle income?
- 6 years are reported by both, from 2000 to 2021.
- How do Estonia and Middle income rank globally for cause of death, by non-communicable diseases, male?
- Estonia ranks 20th and Middle income ranks 21st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.